All In MedTech

FDA Clearance Tracker · P060005-S024

IMMULITE 2000 Free PSA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 21, 2026

Approved

Time to decision

203 days

Received Sep 30, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P060005-S024
Device name
IMMULITE 2000 Free PSA
Applicant location
Gwynedd Ll55
Received
Sep 30, 2025
Decided
Apr 21, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P060005

Device type

Device class
Class III

Every decision under product code MTG

FDA's approval statement

As written in FDA's record.

approval of the instrument manufacturing site change for the IMMULITE 2000XPi analyzer to the Siemens Healthcare Diagnostics instrument manufacturing facility located in Llanberis, Wales

Source documents

Other decisions for Siemens Medical Solutions Diagnostics Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.